about
Lysine-52 stabilizes the MYC oncoprotein through an SCF(Fbxw7)-independent mechanism.Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.MYC overexpression with its prognostic and clinicopathological significance in breast cancer.Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer.AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.1,2,3,4,6-Penta-O-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC Expression.Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models.Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.A modified gene trap approach for improved high-throughput cancer drug discovery.The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues.Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells.Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer
P2860
Q38625813-922F451C-4A78-47C7-AA04-FED00EB5E936Q42281992-07787C7C-9CA1-42AF-85BC-9F9CC3FDCE42Q47356965-FC290F2D-6609-4993-9A6D-8CB8F62B5B84Q48259534-79BA9C16-0E7C-46E0-AEED-04905B172AFBQ49706804-FDAE60FD-E28A-44B5-B4EA-9F5F81BD27C2Q50027280-C233D302-4C4C-483F-B089-3FB0FFAC2507Q50199534-8B2C204A-96F7-4581-8E7C-9BB67BF4CCF8Q52348476-E0407AAF-9EEC-4DD4-83A8-92635BB46FAEQ52595419-9353FBBC-5DD7-4A4B-BB9E-BF6F51F98B31Q52596648-D276A7B4-5BC0-436C-8080-6AECDB72A7E5Q52714926-F6B0E9CF-F3D8-41B6-96F0-24887640E3A8Q52715807-F4B26A3A-0F4F-46DF-90A8-C6FB7CDB9550Q55248424-256D0558-F643-4406-980E-29CDF15FC2E4Q57484740-E96516C8-C2ED-4E7A-917D-8AB437BB024B
P2860
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
MYC Deregulation in Primary Human Cancers.
@ast
MYC Deregulation in Primary Human Cancers.
@en
type
label
MYC Deregulation in Primary Human Cancers.
@ast
MYC Deregulation in Primary Human Cancers.
@en
prefLabel
MYC Deregulation in Primary Human Cancers.
@ast
MYC Deregulation in Primary Human Cancers.
@en
P2093
P2860
P50
P356
P1433
P1476
MYC Deregulation in Primary Human Cancers
@en
P2093
Aaliya Tamachi
Corey Lourenco
Diana Resetca
Katherine Ashley Hickman
William B Tu
P2860
P356
10.3390/GENES8060151
P577
2017-05-25T00:00:00Z